In its Decision, the Board declined to institute the inter partes review of claims 1-23 of the ‘828 patent. It was the Board’s view that Petitioner had not established a reasonable likelihood of prevailing on its positions with respect to these claims.
Monthly Archives: September 2015
Decision Denying Institution IPR2015-00612
In its Decision, the Board denied institution and determined that Petitioner had not demonstrated a reasonable likelihood of prevailing in showing the unpatentability of any of the challenged claims (claims 1-15) of the ’871 Patent. The ’871 Patent relates to “image capture and transmission systems and is specifically directed to an image capture, compression, and transmission system for use in connection with land line and wireless telephone systems.” Continue reading
Granting Institution of Inter Partes Review Over Objection that All Real Parties-in-Interest Were Not Identified IPR2015-00864
In its Decision, the Board granted institution of the challenged claims (1-27) of the ’703 Patent. The ’703 Patent “relates to methods for preventing or treating diseases caused by thrombus or embolus by administering an effective amount of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine, or a pharmaceutically acceptable salt thereof, and aspirin to warm-blooded animals, particularly humans.” Continue reading
Final Written Decision Turning on Claim Construction IPR2014-00639
In its Final Written Decision, the Board concluded that Petitioner has shown by a preponderance of the evidence that claims 1-4 of the ’609 patent are unpatentable. Continue reading
Institution Denied Because No Claim Directed To Financial Product or Service CBM2015-00107
In its Decision, the Board denied institution of covered business method patent review of claims 1-3, 12, 14, 21, 22, 24-26, 35, 37, 44, 45, 56-58, 67, 69, 76, 77, 79, 80, 83, 85, and 88-90 of the ’683 patent. Claim 79 was selected as an exemplary claim for Petitioner’s challenge and the Board’s analysis. Continue reading
Denying Motions to Vacate because Un-named Members of Corporate Group were Separate Entities IPR2015-00808, 814, 815, 818, 819, 823, 824
In its Order, the Board denied Patent Owner’s Motion to Vacate because of an alleged failure of Petitioner to name two corporate entities as real parties in interest (RPI). Patent Owner filed similar Motions to Vacate in seven inter partes review proceedings, alleging that because at least two entities were not identified as an RPI, the Petitions should not be entitled to a filing date, 35 U.S.C. § 312(a)(2), and were therefore time-barred under 35 U.S.C. § 315(b). Continue reading
Conception Not Established in Final Written Decision Finding Challenged Claims Unpatentable IPR2014-00504
In its Final Written Decision, the Board found all challenged claims of the ‘771 patent unpatentable and dismissed Petitioner’s motion to exclude. Specifically, the Board determined that “Petitioner has shown by a preponderance of the evidence that claims 1-4, 7, and 18 of the ‘771 patent are unpatentable.” The ‘771 patent relates to “providing a mobile wireless access point for use with high-speed wireless devices.” Continue reading
Final Written Decision Finding All Challenged Claims Anticipated and Obvious IPR2014-00325
In its Final Written Decision, the Board found that all challenged claims (15-19) of the ’832 Patent are unpatentable. The ’832 Patent generally “relates to compositions and methods for treating narcotic dependence using an orally dissolvable film comprising buprenorphine and naloxone, wherein the film provides a bioequivalent effect to Suboxone®.” “The ’832 patent defines bioequivalent as ‘obtaining 80% to 125% of the Cmax and AUC values for a given active in a different product.’” “According to the ’832 patent, ‘Cmax refers to the mean maximum plasma concentration after administration of the composition to a human subject,’ and ‘AUC refers to the mean area under the plasma concentration-time curve value after administration of the compositions.’” Continue reading
Denying Institution Of Second Petition By Same Petitioner Against Same Patent IPR2015-00776
In its Decision, the Board denied institution of inter partes review (“IPR”) of claims 1-53 of the ’041 patent. The Board stated that the Petition advanced the same challenges to the ’041 patent as the IPR2014-01177 proceeding (“the ’01177 proceeding”) in which the board declined to institute IPR. Continue reading
Institution Denied For Lack Of Articulated Reasoning For The Alleged Combination Of References IPR2015-00320
In its Decision, the Board denied institution of inter partes review (IPR) of claims 1-10 of the ’494 patent. Continue reading